Skip to main content
Tech.euFundingExplorerBeta

Sight Diagnostics

Sight Diagnostics is a medical device company bringing affordable, accurate diagnostics to the point-of-care.

Sight Diagnostics has raised €110M across 3 funding rounds from 6 investors, most recently a Series D+ round in Jul 2020. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Data as of 28 Oct 2026.

Tel Aviv, IsraelFounded 2011www.sightdx.com ↗
Total raised
€110M
€109,975,467
Funding rounds
3
Investors
6
distinct backers
Active since
2018-12
latest 2020-07

Funding by year

EUR raised per year
Sight Diagnostics — funding by year — interactive chart.
Data table
Sight Diagnostics — funding by year
2018€49M
2020€61M

Signals

High confidence
Raise-next likelihood11
base rate 53% for Series D+
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2020-07-26Series D+€61MClal Biotechnology IndustriesView deal →
2019-01-01Series C€24MGo Capital,Jack Nicklaus II,Longliv Ventures,New Alliance Capital,OurCrowdView deal →
2018-12-23Series C€25M—View deal →

Similar companies

same sector or country

Global coverage: FundingData